Skip to main content
Clinical Trials/NCT03466593
NCT03466593CompletedNot Applicable

Effekt av Prehabilitering Och Extra Tidig Mobilisering Efter öppen Pankreas Kirurgi

Göteborg University1 site in 1 country245 target enrollmentStarted: December 18, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
245
Locations
1
Primary Endpoint
PaO2

Study Overview

Brief Summary

Open upper gastrointestinal surgery includes surgery in the upper abdomen such as ventricular, duodenal, pancreatic and biliary tract surgery. After upper abdominal surgery there is a risk of gastrointestinal and cardiopulmonary complications. There is currently insufficient knowledge about the effect of prehabilitation and extra early postoperative mobilization in upper pancreatic surgery.

This study's aim is to evaluate the effect of prehabilitation and extra early mobilization.

The study includes two substudies:

  1. A prospective cohort of 75 patients undergoing pancreatic surgery after a prehabilitation program will be compared to 75 historical controls. Primary outcome is postoperative complications.
  2. A randomized controlled trial based on 72 patients undergoing pancreatic studying the effect of extra early rehabilitation. The intervention group will be mobilized to bedside, standing or sitting in armchair <6 hours after surgery, ie 3-4 hours after arrival at the Postoperative Department (PIVA). The control group will be mobilized according to routine i.e. the morning after surgery. Primary outcome is PaO2.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients scheduled to undergo pancreatic surgery

Exclusion Criteria

  • •in substudy b:
  • •Preoperative injury or disease making it impossible to perform the intervention

Arms & Interventions

Prospective cohort-prehabilitation

Experimental

A prehabilitation program including advice about diet, increased physical activity and cessation of smoking and drinking alcohol.

Intervention: Prehabilitation (Other)

Retrospective cohort

Active Comparator

Routine care before the prehabilitation program was introduced

Intervention: Routine care (Other)

Extra early mobilization

Experimental

Mobilization the day of surgery

Intervention: Extra early mobilization (Other)

Traditional mobilization

Active Comparator

Routine care with mobilization the day after surgery

Intervention: Standard mobilization (Other)

Outcomes

Primary Outcomes

PaO2

Time Frame: The day before surgery to the first day after surgery

Arterial oxygen pressure

Postoperative complications

Time Frame: Whole study period from inclusion to one year after surgery

Standardized complications according to register

Secondary Outcomes

  • EORTC-module generic(Whole study period from inclusion to one year after surgery)
  • EORTC-module specific for pancreas cancer(Whole study period from inclusion to one year after surgery)
  • EORTC-module for fatigue(Whole study period from inclusion to one year after surgery)
  • The Postoperative Recovery Profile(Whole study period from inclusion to one year after surgery)
  • Spirometry(From inclusion (during preoperative information 1-14 days before surgery) to the first postoperative day after the operation)
  • Lenght of stay(From the day before surgery to discharge from the hospital (app 7-14 days))
  • Pancreatic cancer disease impact (PACADI) score(Whole study period from inclusion to one year after surgery)

Investigators

Sponsor
Göteborg University
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials